KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Cash from Financing Activities (2016 - 2026)

Pacific Biosciences Of California has reported Cash from Financing Activities over the past 16 years, most recently at $1.5 million for Q3 2025.

  • For Q3 2025, Cash from Financing Activities rose 80.91% year-over-year to $1.5 million; the TTM value through Dec 2025 reached $3.4 million, up 107.97%, while the annual FY2025 figure was $3.4 million, 107.97% up from the prior year.
  • Cash from Financing Activities for Q3 2025 was $1.5 million at Pacific Biosciences Of California, down from $2.0 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $865.7 million in Q1 2021 and troughed at -$81.6 million in Q4 2023.
  • A 5-year average of $55.8 million and a median of $1.3 million in 2021 define the central range for Cash from Financing Activities.
  • Biggest five-year swings in Cash from Financing Activities: skyrocketed 4656.97% in 2021 and later tumbled 10063.61% in 2023.
  • Year by year, Cash from Financing Activities stood at $1.3 million in 2021, then plummeted by 38.14% to $819000.0 in 2022, then tumbled by 10063.61% to -$81.6 million in 2023, then skyrocketed by 38.48% to -$50.2 million in 2024, then skyrocketed by 102.93% to $1.5 million in 2025.
  • Business Quant data shows Cash from Financing Activities for PACB at $1.5 million in Q3 2025, $2.0 million in Q1 2025, and -$50.2 million in Q4 2024.